about
9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in MiceSLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cellsIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12Structural basis for the activation of PPARgamma by oxidized fatty acidsStructural basis for the assembly of the SMRT/NCoR core transcriptional repression machineryRetinoid X receptors: X-ploring their (patho)physiological functionsReprogramming of lysosomal gene expression by interleukin-4 and Stat6Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases.Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells.Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans.Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targetsPharmacogenetics and pharmacogenomics in rheumatology.Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules.Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cellsSTAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cellsTwenty years of nuclear receptors: Conference on Nuclear Receptors: from Chromatin to Disease.PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationLigand binding shifts highly mobile retinoid X receptor to the chromatin-bound state in a coactivator-dependent manner, as revealed by single-cell imaging.Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffin-embedded samples.Mapping the genomic binding sites of the activated retinoid X receptor in murine bone marrow-derived macrophages using chromatin immunoprecipitation sequencing.Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cellsRibonucleoprotein-masked nicks at 50-kbp intervals in the eukaryotic genomic DNA.Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration.PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cellsRoles for lipid-activated transcription factors in atherosclerosis.PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function.PPARgamma in immunity and inflammation: cell types and diseases.Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function.Potential Therapeutic Use of PPARgamma-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells.The many faces of PPARgamma: anti-inflammatory by any means?Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases.The triad of success in personalised medicine: pharmacogenomics, biotechnology and regulatory issues from a Central European perspective.
P50
Q21092399-71730617-E533-416C-932A-426407A91DBBQ24297438-C7DA8C01-D713-4668-8454-ED2FE40A9B34Q26739984-22CED79D-C644-48BF-AB94-C44B93122000Q27637227-A7B37F2A-A97E-402D-8D3E-683D046200BBQ27653525-ED46A5E7-4763-408A-B92D-BCBEFD19E655Q27666601-87AA1111-774B-48F5-80C8-5D99284F6B5FQ28299087-302AD949-9CB3-47DD-B0B4-3E913FF49E0EQ28393663-DCFE4145-9721-4605-9162-F2C98CCCAAC8Q30886916-FECA2D44-0D2C-480D-BBED-ACDD7C9C095AQ33247258-3458EA12-F786-43A2-B035-FE1553141B5FQ33307393-961E66F9-8A30-48AD-929E-206C6832B71CQ33863511-CAF16447-AF90-42E3-BB1B-7F0A94822A1EQ33869998-3C567489-02DD-497E-9313-C75508895783Q34070615-C2844670-58D0-4D00-8799-C8213DAFB6B7Q34335599-FF6A7128-6A3B-4E4F-B80C-D7317FCD41DFQ34518904-89190ED3-EB9F-4C0A-BBAF-55160FEF0755Q34576151-A2406B9A-7348-49A1-A8F9-4DEE9C94DC9AQ34603375-44D3531F-A329-401B-B1AE-E744E04E8E35Q34641231-BBB7B466-C827-483D-9E2C-F19FA4F22B6DQ34683388-0F816E47-78C9-43C2-BB13-7457F9EAA19DQ35017820-5B30B408-03DB-4FD7-93BD-C7660A15081BQ35053566-6EA58943-C139-4677-B702-2E63DF96F18AQ35085914-56E6C854-D3D9-424A-A5D9-F5BB0E5A7F90Q35211950-5DAEAD29-80E0-409D-8C30-A4104CB7F4CCQ35237127-6DAB0C09-88C7-4004-A3A5-7FE0890367E8Q35677716-54774D50-2BA9-43F7-9FAE-20F738DB0368Q35791452-43A65E22-83A7-4C39-BA2C-483E337375B8Q36002520-6C8526FD-5237-4E46-94A4-9B277914937DQ36190424-74F2BD2D-2B19-4573-902B-9F744297C1F2Q36227984-3D95C34E-7916-4268-9D51-B761390A59D5Q36278716-3B273846-9328-4D3D-AFC1-593FF8C3F4F5Q36693982-C091B68B-DDF1-43EA-9DE5-C4A1267DD37CQ36785477-BF83BDA1-4AAC-4A4D-954C-45B7C781366CQ36852547-3CC60AE6-C99A-4C30-BD3C-8F0EB6B689C5Q36969083-97048C5F-A0AB-4DB4-B3E1-CFFEDF25D922Q37287837-8AB22D5B-0C99-4722-A39F-BE734B6620F7Q37294947-4A7D45AD-0BD7-48D8-827D-61D7AFEA9C19Q37300253-0BEAA5A1-315F-41E9-ACBA-80C453DEB5A0Q37851230-627A1F6F-A1C8-4992-A8EA-FA735DA88756Q37993326-9B8FDA73-2472-4BD4-8902-0E1A1523E3BE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laszlo Nagy
@ast
Laszlo Nagy
@en
Laszlo Nagy
@es
Laszlo Nagy
@nl
Laszlo Nagy
@sl
type
label
Laszlo Nagy
@ast
Laszlo Nagy
@en
Laszlo Nagy
@es
Laszlo Nagy
@nl
Laszlo Nagy
@sl
prefLabel
Laszlo Nagy
@ast
Laszlo Nagy
@en
Laszlo Nagy
@es
Laszlo Nagy
@nl
Laszlo Nagy
@sl
P106
P21
P31
P496
0000-0001-6653-2155